Literature DB >> 16867634

Degradation of busulfan in aqueous solution.

M Hassan1, H Ehrsson.   

Abstract

The influence of pH, phosphate buffer components and temperature on the degradation rate of busulfan was studied. The analysis was performed using gas chromatography with electron capture detection and reversed-phase liquid chromatography with radioactivity monitoring. The degradation rate of busulfan showed no pH dependence in the range pH 1.5-11 and increased at higher pH values. The degradation rate constant was 0.034 +/- 0.001 h(-1) (S.E.M.) for the degradation of busulfan in pure water and 0.45 +/- 0.01 h(-1)M(-1) (S.E.M.) for the reaction of busulfan with the hydroxide ion at 37 degrees C. The reactivity of HPO(4)(-2) was six times higher than the reactivity of H(2)PO(4)(-1) towards busulfan. The hydrolysis products were identified as tetrahydrofuran and methanesulphonic acid by nuclear magnetic resonance spectroscopy.

Entities:  

Year:  1986        PMID: 16867634     DOI: 10.1016/0731-7085(86)80027-9

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  The Myeloablative Drug Busulfan Converts Cysteine to Dehydroalanine and Lanthionine in Redoxins.

Authors:  Michele Scian; Miklos Guttman; Samantha D Bouldin; Caryn E Outten; William M Atkins
Journal:  Biochemistry       Date:  2016-08-11       Impact factor: 3.162

Review 2.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

3.  Gas-chromatographic analysis of busulfan for therapeutic drug monitoring.

Authors:  L Embree; R B Burns; J R Heggie; G L Phillips; D E Reece; J J Spinelli; D O Hartley; N J Hudon; J H Goldie
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain.

Authors:  M Hassan; H Ehrsson; I Wallin; S Eksborg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

5.  Metabolism of 14C-busulfan in isolated perfused rat liver.

Authors:  M Hassan; H Ehrsson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

6.  Pharmacokinetics and metabolism of the antitumor agent sulfamic acid 1,7-heptanediyl ester (sulfamic acid diester) in the mouse and beagle dog.

Authors:  J I Brodfuehrer; T J Wilke; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Airborne cytotoxicity in the DiSC assay caused by solutions of treosulfan but not busulphan.

Authors:  A G Bosanquet; A R Burlton
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 8.  Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Authors:  Alan L Myers; Jitesh D Kawedia; Richard E Champlin; Mark A Kramer; Yago Nieto; Romi Ghose; Borje S Andersson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-08-17       Impact factor: 4.481

9.  Physico-chemical stability of busulfan in injectable solutions in various administration packages.

Authors:  Mélanie Houot; Vianney Poinsignon; Lionel Mercier; Cyril Valade; Romain Desmaris; François Lemare; Angelo Paci
Journal:  Drugs R D       Date:  2013-03

10.  Use of Busulfan to Condition Mice for Bone Marrow Transplantation.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  STAR Protoc       Date:  2020-11-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.